Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma

NCT03702491 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Gallbladder Carcinoma

Interventions

DRUG: Apatinib
DRUG: Tegafur

Sponsor

Eastern Hepatobiliary Surgery Hospital